On the Bombay Stock Exchange, 8% shares of the Vivimed Labs and BSE said after the company that the United States Food and Drug Administration they recently inspected the company's manufacturing plant in Spain and issue 'zero' 483 observation.

Following the announcement, shares of the company gained as much as 8.42 per cent to hit intra-day high of Rs 113.90 apiece on the Bombay Stock Exchange. The scrip was currently trading at Rs 111.50 against the previous close price of Rs 105.05.

In a similar fashion, stocks of the company were trading 6.29 per cent higher at Rs 111.55 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,322.09, up 131.52 points or 0.42 per cent, at 10:45 hours.